Transforming the Psychiatric Inpatient Unit from Short-term Pseudo-asylum Care to State-of-the-art Treatment Setting
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Scott J, Langsrud K, Vethe D, Kjorstad K, Vestergaard C, Faaland P Trials. 2019; 20(1):472.
PMID: 31370871 PMC: 6676579. DOI: 10.1186/s13063-019-3582-2.
DMello D Psychiatry (Edgmont). 2009; 5(11):15.
PMID: 19724711 PMC: 2695718.
References
1.
Benkert O, Grunder G, WETZEL H, Hackett D
. A randomized, double-blind comparison of a rapidly escalating dose of venlafaxine and imipramine in inpatients with major depression and melancholia. J Psychiatr Res. 1996; 30(6):441-51.
DOI: 10.1016/s0022-3956(96)00029-5.
View
2.
Tzanakaki M, Guazzelli M, Nimatoudis I, Zissis N, Smeraldi E, Rizzo F
. Increased remission rates with venlafaxine compared with fluoxetine in hospitalized patients with major depression and melancholia. Int Clin Psychopharmacol. 2000; 15(1):29-34.
DOI: 10.1097/00004850-200015010-00004.
View
3.
Zarate Jr C, Singh J, Carlson P, Brutsche N, Ameli R, Luckenbaugh D
. A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry. 2006; 63(8):856-64.
DOI: 10.1001/archpsyc.63.8.856.
View
4.
Guducu F, Caliyurt O, Vardar E, Tuglu C, Abay E
. [Combination therapy using sertraline with sleep deprivation and light therapy compared to sertraline monotherapy for major depressive disorder]. Turk Psikiyatri Derg. 2005; 16(4):245-51.
View
5.
Golden R, Gaynes B, Ekstrom R, Hamer R, Jacobsen F, Suppes T
. The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence. Am J Psychiatry. 2005; 162(4):656-62.
DOI: 10.1176/appi.ajp.162.4.656.
View